16 Mar 2016
In line prelims and positive market backdrop N+1 Singer view
Another in line set of prelims despite an FX headwind. There was a mixed performance at a divisional level, with Branded Distributed sales the star performer, driven by a near doubling of LiquiBand sales in the US and a first full contribution for the Fix8 device of £1.0m. We expect this will now be submitted for FDA approval to launch in the US, a ~3 year process. The FX headwinds should reverse this year, so we see scope for a ~5% upgrade, which still leaves the shares trading at a premium rat ....
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
In line prelims and positive market backdrop N+1 Singer view
Advanced Medical Solutions Group plc (AMS:LON) | 192 3.5 0.9% | Mkt Cap: 417.5m
- Published:
16 Mar 2016 -
Author:
Chris Glasper -
Pages:
3
Another in line set of prelims despite an FX headwind. There was a mixed performance at a divisional level, with Branded Distributed sales the star performer, driven by a near doubling of LiquiBand sales in the US and a first full contribution for the Fix8 device of £1.0m. We expect this will now be submitted for FDA approval to launch in the US, a ~3 year process. The FX headwinds should reverse this year, so we see scope for a ~5% upgrade, which still leaves the shares trading at a premium rat ....